| 14 mai 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 1 177 222 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 41 250 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 41 250 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 10 030 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 10 030 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 12 920 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 12 920 | — | |
| 14 mai 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 25 840 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 25 840 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 4 909 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 3 372 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 11 284 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 25 840 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 108 622 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 82 500 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 110 000 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 95 000 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 50 974 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 56 250 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 45 000 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 30 845 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 9 805 | — | deriv |
| 28 janv. 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 25 840 | 0.00 USD | |
| 22 janv. 2026 | SALE | Apellis Pharmaceuticals, Inc. | 5 928 | 21.77 USD | |
| 20 janv. 2026 | SALE | Apellis Pharmaceuticals, Inc. | 909 | 19.79 USD | |